ZIMMER BIOMET HOLDINGS INC (ZBH)
Sector: Health Care
| Ticker | Position | Age | Qualifications and Experience | Committee Memberships | Filing Year |
|---|---|---|---|---|---|
Sector: Health Care
| Ticker | Position | Age | Qualifications and Experience | Committee Memberships | Filing Year |
|---|---|---|---|---|---|
Director information for ZBH
| Ticker | Position | Age | Qualifications and Experience | Committee Memberships | Filing Year |
|---|---|---|---|---|---|
| ZBH | Chairman, President and Chief Executive Officer; Chairman, President & CEO, Embecta Corp. | 57 | ["Extensive experience in the medical device industry", "Experience with connected medical devices", "Insights on global business, operations and manufacturing, strategy and innovation, cybersecurity, risk and crisis management, investor relations and regulatory and compliance matters"] | [] | 2026 |
Companies shown below are based on exact name match for the selected Director
| Ticker | Position | Age | Qualifications and Experience | Committee Memberships | Filing Year |
|---|---|---|---|---|---|
| EMBC | President and Chief Executive Officer, Embecta Corp. | 57 | ["experienced healthcare executive", "extensive experience in the medical device industry", "experience with global business, operations and manufacturing", "strategy and innovation", "cybersecurity and information systems", "risk and crisis management", "ESG", "regulatory and compliance matters", "experience with institutional investors"] | ["AdvaMed", "LMG Holdings", "Zimmer Biomet Holdings, Inc."] | 2025 |
Biography sourced from the proxy statement filing.
Chairman, President and Chief Executive Officer of Embecta Corp., a global medical device company (embecta), since February 2026, and President, Chief Executive Officer and director of embecta since its spinoff from Becton, Dickinson and Company (BD) in April 2022. Mr. Kurdikar was the Worldwide President of Diabetes Care at BD from 2021 until the spinoff. Prior to joining BD, Mr. Kurdikar was President and CEO of Cardiac Science Corporation from 2016 to 2019. Prior to that role, Mr. Kurdikar was the Vice President and General Manager, Men's Health, within Urology and Pelvic Health at Boston Scientific Corporation (Boston Scientific) from 2015 to 2016. Mr. Kurdikar served in the same role at American Medical Systems (AMS) starting in 2013 and led the Men's Health business through its carve-out, sale and integration into Boston Scientific. Before joining AMS, Mr. Kurdikar worked for 11 years with Baxter International, Inc., holding leadership roles of increasing responsibility in finance, strategy and integration, R&D planning and operations, ultimately serving as Vice President, Marketing, from 2011 through 2013. He began his career as a Senior Research Engineer at The Monsanto Company. Mr. Kurdikar holds a Bachelor in Chemical Engineering from the University of Bombay (India). He earned a Master of Science in Chemical Engineering from Washington State University, a Ph.D. in Chemical Engineering from Purdue University, and a Master of Business Administration from Washington University. In addition to serving on the embecta board, Mr. Kurdikar serves on the board of directors of AdvaMed. Other Public Board Memberships Embecta Corp. Other Relevant Experience Director of AdvaMed Skills and Qualifications Devdatt (Dev) Kurdikar is an experienced healthcare executive who brings extensive experience in the medical device industry and with medical device technology, including connected medical devices. As Chief Executive Officer of a global medical device company, Mr. Kurdikar also provides our Board with valuable insights on matters pertaining to, among others, global business, operations and manufacturing, consumer/retail, strategy and innovation, cybersecurity, risk and crisis management, investor relations and regulatory and compliance matters, as well as experience with institutional investors.